Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.EpiCept prices public offer at $0.25
EpiCept will receive approximately $0.5 million in net proceeds from the offering. Rodman & Renshaw, a subsidiary of Rodman & Renshaw Capital Group, is acting as the exclusive
EpiCept will receive approximately $0.5 million in net proceeds from the offering. Rodman & Renshaw, a subsidiary of Rodman & Renshaw Capital Group, is acting as the exclusive
In connection with the private placement, investors received three year warrants to purchase an aggregate of 4.3 million shares of common stock at an exercise price of $0.90
The Phase Ia trial is a placebo-controlled single ascending dose clinical trial. The trial is designed to evaluate the safety and tolerability of A0001 at various doses and
Additionally, based on current discussions, Hemispherx management sees the potential for a mutually beneficial new Ampligen partnership with the principals now controlling Bioclones and Ribotech. As part of
WellPoint is currently partnering with CareNex to expand its affiliated health plans’s Neonatal Intensive Care (NICU) services program for members in those plans in Virginia and New York,
As previously announced, Allergan paid approximately $150 million for all assets relating to Aczone gel 5%. Allergan expects to launch Aczone gel 5% in the fourth quarter of
Under the terms of the agreement, rights to ViroNovative’s human metapneumovirus (hMPV) intellectual property will be extended to Luminex’s distributors and end-user customers around the world. Luminex’s xTAG
The safety data from the final analysis also shows that vernakalant (oral) was well-tolerated in the atrial fibrillation population studied. The final results demonstrated that the 500mg dosing
MitoSciences has patent pending tests for measuring pyruvate dehydrogenase (PDH) activity in both high-throughput and clinical platforms, and intends to use the newly accessed proteins to provide complete
The Certified Service Provider program comprises a select list of strategic organizations that pass a rigorous assessment to use Agilent’s microarray platform. The program combines the provider’s focused